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Abstract
The search for diagnostic biomarkers for pulmonary embolism (PE) has mainly been focused on
blood samples. Exhaled breath condensate (EBC) is a possible source for biomarkers specific for
chronic lung diseases and cancer, yet no previous studies have investigated the potential of EBC for
diagnosis of PE. The protein content in the EBC is very low, and efficient condensing of the EBC is
important in order to obtain high quality samples for protein analysis. We investigated if advanced
proteomic techniques in a porcine model of acute intermediate-high-risk PE was feasible using two
different condensing temperatures for EBC collection. Seven pigs were anaesthetized and
intubated. EBC was collected one hour after intubation. Two autologous emboli were induced
through the right external jugular vein. Two hours after the emboli were administered, EBC was
collected again. Condensing temperature was either−21 ◦C or−80 ◦C. Nano liquid
chromatography-tandem mass spectrometry (nLC-MS/MS) was used to identify and quantify
proteins of the EBC. A condensing temperature of−80 ◦C significantly increased the EBC volume
compared with−21 ◦C (1.78± 0.25 ml vs 0.71± 0.12 ml) while the protein concentration in the
EBC was unaltered. The mean protein concentration in the EBCs was 5.85± 0.93 µg ml−1,
unaltered after PE. In total, 254 proteins were identified in the EBCs. Identified proteins included
proteins of the cytoplasm, nucleus, plasma membrane and extracellular region. The protein
composition did not differ according to condensing temperature. The EBC from pigs with acute
intermediate-high-risk PE contained sufficient amounts of protein for analysis by nLC-MS/MS.
The proteins were from relevant cellular compartments, indicating that EBC is a possible source for




EBC exhaled breath condensate
LFQ label free quantification
nLC-MS/MS nano liquid chromatography-tandem
mass spectrometry
HR heart rate
MRI magnetic resonance imaging
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F French
TFA trifluoroacetic acid
AGC automatic gain control
CID collision-induced dissociation
NTA nanoparticle tracking analysis
PCA principal component analysis
1. Introduction
PE was estimated to account for more than 300 000
deaths among 454 million Europeans in 2004 [1].
This frequent and potentially fatal condition remains
a diagnostic challenge. Initial symptoms vary from
sudden death over classic clinical presentation with
dyspnea, hemoptysis and pleuritic pain to vague
symptoms as syncope, or even asymptomatic present-
ation of central PE [2, 3]. A low (negative) D-
dimer can be used to rule out PE in patients with
low pretest probability of PE, however in patients
with high pretest probability of PE a low D-dimer
is not sufficient to exclude PE [4, 5]. The D-dimer
is often increased for other reasons in hospital-
ized patients and, consequently, the positive pre-
dictive value of a positive D-dimer is low [3]. The
quality of CT angiography can lead to overdia-
gnosis of PE as well as false negative results, even in
patients with high pretest probability of PE [6, 7].
Therefore, it is essential to search for novel bio-
markers that can facilitate the diagnosis of PE, and
a possibility could be to explore the potential of
another sample material from the lungs, i.e. the
expiratory air.
Over the past 30 years methods for non-invasive
sampling of the lower respiratory tract lining fluid
have developed. One of these methods accumulates
the condensate of the expired air by instant cooling of
the exhaled breath, i.e. EBC. The vast majority of EBC
is condensed water vapor, while volatile and non-
volatile molecules including proteins only comprise
a minor fraction. Despite the low protein content in
EBC, advances inmass spectrometry based proteomic
techniques allow for identification and quantification
of EBC proteins [8, 9]. The goal of proteomic stud-
ies is to identify and quantify the most conprehens-
ive set of proteins in a given sample material. Proteins
of the EBC may potentially serve as biomarkers for
PE, but EBC has never been analyzed with proteomic
techniques in PE.
The purpose of this study was to investigate
if collection of EBC in a porcine model of acute
intermediate-high-risk PE yielded amounts of pro-
tein sufficient for LFQ by nLC-MS/MS, and, further-
more, to see whether the amount of specific proteins
in EBC changed after PE as potential diagnosticmark-
ers. We also investigated if extracellular vesicles were
detectable in the EBC before and after PE. During this
pilot-study we adapted the model system to improve
the protein yield since we hypothesized that a lower
initial EBC condensing temperature would increase




Seven female Danish Landrace pigs of 60 kg were
included in this pilot-study which was a part of
a recently published study where a new, autolog-
ous intermediate-high-risk PE porcine model was
developed and characterized primarily in order to
allow tests of novel therapeutic modalities [10].
Anesthesia, ventilation, monitoring and catheteriza-
tions of the pigs and embolus formation is compre-
hensively described in this paper [10]. The experi-
mental pigs were bred at a local specific pathogen
free farmer and transferred to the research animal
facility at Aarhus University for quarantine at least
7 d before the day of the experiment. The study
protocol was approved by the Danish Animal Exper-
iment Inspectorate (license number: 2016-15-0201-
00840), the experiments followed national and inter-
national guidelines concerning ethical care of exper-
imental animals and Danish legislation on transport
of livestock.
In short, anesthesia was induced with intraven-
ous Etomidate (0.5 mg kg−1, Hypnomidate®Janssen
Parmaceutical, Belgium) and maintained after intub-
ationwith continuous intravenous infusion of Propo-
fol (2 mg kg−1 h−1, Propolipid, Fresenius Kabi, Ger-
many) and Fentanyl (5µg kg−1 h−1, Hamlen Pharma,
Germany). Pressure controlled volume ventilation
(Datex-Ohmeda S/5 Avance) with non-humidified
air, tidal volume of 8 ml kg−1, respiratory rate of
16 breaths min−1 and no positive end-expiratory
pressure was initiated. At the end of the experiment,
the animals were euthanized by intravenous injec-
tion of an overdose of Phenobarbital (67 mg kg−1,
Exagon®, vet, Richter Pharma, Austria).
2.2. Catheterizations and embolus formation
Intravascular catheters were placed guided by ultra-
sound in the left femoral artery and the left external
jugular vein for continuous infusion of the anes-
thetics, drawing of blood for the emboli and blood
samples and measurement of blood pressure and
HR. In total 120 ml of autologous, venous blood
was drawn for the emboli and distributed to 4.75′′
uncoated extra corporal tubes and left for coagula-
tion at room temperature for approximately three
hours. Serum was discarded before the embolus was
transferred to an uncoated tube containing isotonic
saline, which was then connected to a 26 F Dry-Seal
sheath placed in the right external jugular vein. Iso-
tonic saline was used to gently flush the embolus
through the 26 F Dry-Seal sheath to the right atrium,
from where the embolus was transported to the pul-
monary artery system by the circulation. Two emboli
were administered for each pig. The exact position of
2
J. Breath Res. 15 (2021) 026005 I L Gade et al
Figure 1. Study schedule. Time from study start is indicated in minutes. Abbreviations: PE, pulmonary embolism; EBC, exhaled
breath condensate; MRI, magnetic resonance imaging; cat., catheterization.
the emboli was evaluated by MRI after each embolus.
Cardiac output and dimensions of the right vent-
ricle were obtained by MRI. Mean pulmonary artery
blood pressure were measured at baseline and after
induction of each embolus by a Swan-Ganz catheter
introduced through the 26 F Dry-Seal sheath.
2.3. Collection and handling of exhaled breath
condensate
Two series of EBC collection were carried out in each
pig; the first sample (Pre PE EBC) was collected after
approximately 1 h of mechanical ventilation, after
insertion of the catheters in the femoral artery and in
the left external jugular vein, but before catheteriza-
tion of the right external jugular vein. Second round
of EBC collection (Post PE EBC) was initiated after
administration of both emboli, which was approx-
imately 21/2 h after induction of the first pulmon-
ary embolus (figure 1). For pig numbers 5, 6 and 7,
two consecutive EBC samples were collected before
PE (Pre PE EBC_a and Pre PE EBC_b) and two EBC
samples were collected after PE (Post PE EBC_a and
Post PE EBC_b).The experimental schedule is out-
lined in figure 1.
The EBC was collected from the expiratory
limb of the mechanical ventilator by insertion of
a polypropylene collection tube (RTubeVent, Res-
piratory Research Inc., Austin, TX, USA) posi-
tioned inline just after the Y-connector (sup-
plementary figure 1 which is available online at
stacks.iop.org/JBR/15/026005/mmedia). An alu-
minum cooling sleeve surrounding the collection
tube precooled to either−21 ◦Cor−80 ◦Ccondensed
the vapor of the exhaled breath. The condensing tem-
perature was−21 ◦C in the first experimental animals
as recommended by the manufacturer. Since we real-
ized that this cooling sleeve almost reached ambient
temperature during the collection of condensate, we
tried to increase the condensation efficiency by lower-
ing the condensing temperature to−80 ◦C in the Post
PE EBC sample from pig number 5 and throughout
the rest of the experiment. The cooling sleeve was
insulated to reduce heating during the 15–20 min
of EBC collection. The heat and moisture exchanger
filter was disconnected during EBC collection. Imme-
diately after collection, the EBC samples were stored
in the collection tubes at−80 ◦C until analysis.
2.4. Estimation of protein concentration in EBC
The EBC volume was estimated in connection with
the protein analysis either by pipetting or by weigh-
ing assuming 1 g = 1 ml. Protein concentration was
estimated by tryptophan fluorescence, essentially as
described previously for peptide measurements [11].
Samples were vacuum centrifuged and re-dissolved in
120 µl digestion buffer (0.5% SDC, 20 mM TEAB).
The fluorescence (Excitation at 295 nm, Emission
at 350 nm) was measured in microtiter trays using
100 µl. A standard curve was constructed from
tryptophan. The protein concentrationwas estimated
under the presumption that 1 g of protein corres-
ponds to 0.0117 g of tryptophan as it is the case for
human and mouse protein samples [12].
2.5. Statistics concerning clinical data and protein
changes
Protein concentrations and EBC volumeswere graph-
ically summarized depicting medians and interquart-
ile range (25th–75th percentiles) and lower and upper
values within 1.5 times the interquartile range.
In analysis where clinical data, protein concen-
trations and EBC volumes were compared accord-
ing to initial condensing temperature, data were
analyzed as independent samples by the Students
t-test. The assumption of normality was checked by
inspection of Q–Q plots, and when violated the Wil-
coxon rank sum test was used. Estimates are given as
mean± standard error of the mean (SEM).
When the data were compared according to col-
lection time (Pre PE vs Post PE) data were analyzed
as paired samples based on the t-test, assumptions
of equal distributions and normality was checked
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by Bland–Altman plots and Q–Q plots of the dif-
ferences, respectively. Statistical analysis of clinical
data and descriptive statistics of protein amount, con-
centrations and EBC volumes were performed in
STATA version 14.0 (Stata Corporation, College Sta-
tion, Texas, USA) software package.
The LFQ intensities for proteins with at least two
identified peptides in EBC samples collected before
PE were compared with the EBC samples collected
after PE using two-sided t-tests with no correction
for multiple comparisons, p-values <0.05 were con-
sidered significant.
2.6. Filter-aided sample preparation with
in-solution digestion and phase transfer
Protein digestion was performed using Microcon
30 K centrifugal filter devices (Merck Milipore Ltd,
Tullagreen, IRL), essentially as described [11] with
slight modifications. The EBC sample was added to
the filter device and centrifuged at 14 000 g for 10min.
A 100 µl of 50 mM iodoacetamide was added, mixed
at 600 rpm for 1 min and incubated at room temper-
ature for 20min in the dark. The filter was centrifuged
and 100 µl digestion buffer was added two times each
followed by centrifugation. Then 35 µl digestion buf-
fer was added together with 0.5 µg of trypsin and left
overnight at 37 ◦C in a wet chamber. A 50 µl diges-
tion buffer was added and the filter unit centrifuged
at 14 000 g for 10 min with new collection tubes. TFA
was added to a final concentration of 0.5% (v/v) and
an equal sample volume of ethyl acetate was added,
shaken for 1 min and centrifuged at maximum speed
for 2 min. The lower phase was saved by removal
of the upper phase. The extraction was repeated two
times. The samples were dried in a vacuum centrifuge
and re-suspended in 0.1% (v/v) formic acid.
2.7. Nano liquid chromatography-tandemmass
spectrometry (nLC-MS/MS)
The peptide mixture was separated by nLC on an
UltiMate 3000 (Thermo Scientific) coupled to an
Orbitrap Fusion mass spectrometer (Thermo Sci-
entific) through an EASY-Spray source (Thermo Sci-
entific). A trap column (300 µm × 5 mm, C18
PepMap100, 5 µm, 100 Å, Thermo Scientific) was
used to load the sample and an analytical column
(EASY-Spray Column, 500 mm × 75 µm, PepMap
RSCL, C18, 2 mm, 100 Å, Thermo Scientific) was
used to separate peptides. The peptides were eluted
with a flow of 300 nl min−1 using a 60 min gradient
by mixing buffer A (0.1% formic acid) with buffer B
(80% acetonitrile, 20% water, 0.1% formic acid). The
following amounts of buffer B were used, 6% (0min),
16% (3 min), 30% (30 min), 60% (38 min), 99%
(40 min), 99% (50 min), 6% (51 min), 6% (60 min).
The universal method setting was used for mass spec-
trometry detectionwith fullOrbitrap scans (m/z 400–
1500) at a resolution of 120 000. An AGC target of
4 × 105 and a maximum injection time of 50 ms was
used. The cycle time was 3 s. The most intense pre-
cursors were selected with an intensity threshold of
5 × 103 in top speed data dependent mode. MS [2]
scans were performed in the linear ion trap in auto
scan rangemodewith CID energy set to 35%, an AGC
target of 2 × 103 and a maximum injection time of
300 ms. The precursor ions with charge states 2–7
were isolated using the quadrupole with an isolation
window of 1.6m/z. Dynamic exclusionwas set to 60 s.
2.8. Identification and label-free quantification of
proteins
The raw data files were used to search the Sus scrofa
and Homo sapiens Uniprot databases each down-
loaded on the 22 February 2017, using MaxQuant
(v1.5.5.1) for LFQ analysis [13]. The settings in
MaxQuant have previously been described [14].
Ideally, the raw files that were based on tryptic pig
peptides, should thus be used to search for pro-
tein identifications in the Sus scrofa protein database.
However, the Sus scrofa database is not as compre-
hensive as the Homo sapiens database, so if the ini-
tial searches were restricted to the Sus scrofa data-
base, the number of protein identifications would be
modest. Our experience is that several human and pig
tryptic peptides are identical. This first analysis was
performed using MaxQuant based on the raw data-
files with m/z values of tryptic peptides and colli-
sion induced fragments. MaxQuant combines indi-
vidually identified peptides into protein groups with
quantification data. The false discovery rate (FDR)
was set to 1% at peptide spectrum match level as
well as at protein level. The data fromMaxQuant was
entered into Perseus (v1.5.8.5) for statistical analysis
[15] finally describing expressed proteins which will
be based on a mixture of proteins identified in the
Sus scrofa database as well as in the Homo sapiens
database. Proteins were filtered by removing poten-
tial contaminants, proteins identified as reverse hits
and proteins only identified by site. LFQ-values were
log2 transformed. Technical replicates were averaged
bymean. The samples were then categorized as Pre PE
EBC or Post PE EBC and also according to condens-
ing temperature (−21 ◦C or −80 ◦C). Proteins were
filtered by requiring razor+ unique peptides > 1. The
proteins were further filtered by requiring that each
protein was identified in all EBC samples prior to PE
and after PE. Gene and protein names were added
manually for thirteen proteins identified in the Sus
scrofa Uniprot database (accession numbers: P00355,
P00506, P01965, P02067, P08835, P09571, P50828,
P53715, P79260, P80031, P81608, Q29092). No gene
name was available for the protein with accession
number P81245 (Odorant-binding protein).
2.9. Bioinformatics
A bioinformatic analysis was conducted based on
the gene names of proteins identified in 100% of
the samples using GeneCodis3 to bring insights into
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Table 1. Clinical data, functional and invasive measures before and after PE.
Before PE (n= 7) After PE (n= 7) p-value
Heart rate (beats min−1) 43± 3 85± 12 0.01
Mean arterial blood pressure (mmHg) 73± 5 77± 3 0.35
Cardiac output (l min−1) 4.4± 0.47 4.3± 1.24 0.70
Right ventricle end systolic volume (ml) 61.3± 5.8 98.0± 7.3 < 0.001
Ejection fraction (%) 59± 3 39± 4 < 0.001
Mean pulmonary arterial pressure (mmHg) 16± 1 29± 2 < 0.001
End tidal-CO2 (kPa) 5.0± 0.1 5.4± 0.2 0.14
pH 7.46± 0.03 7.44± 0.02 0.49
PaCO2 (kPa) 5.2± 0.1 6.3± 0.2 0.003
PaO2 (kPa)
a 21.1± 1.8 21.3± 7.4 0.99
Base excess (mmol l−1) 4.5± 1.2 7.4± 0.7 0.04
Lactate (mmol l−1) 2.5± 0.5 1.1± 0.2 0.05
Rectal temperature 35.8± 0.4 39.1± 0.6 < 0.001
Abbreviations: SEM, standard error of the mean; PaCO2, arterial CO2 tension; PaO2, arterial O2 tension.
a For the five animals who did not receive supplemental oxygen: PaO2 before PE: 21.3± 2.6, PaO2 after PE: 12.5± 0.4, p-value= 0.04.
the Gene Ontology aspect: ‘Cellular Component’ of
proteins identified in the EBCs [16–18]. To ensure
that all proteins were recognized in GeneCodis3 the
gene names were entered, Homo sapiens was chosen
as organism and ‘Cellular component’ was chosen.
In GeneCodis, a hypergeometric test was used and p-
values were corrected using the FDR method of Ben-
jamini andHochberg [19]. ‘Cellular component’ with
a corrected p-value <0.05 was accepted as statistically
significant.
2.10. Principal component analysis (PCA)
A PCA analysis was conducted using default settings
in Perseus in order to analyze if the protein expression
patterns varied based on initial condensing temperat-
ure. The PCA analysis was based on proteins identi-
fied in all the EBC samples in the dataset. The LFQ
values were log2 transformed before the analysis. The
samples were classified as either ‘condensing temper-
ature−21 ◦C’ or ‘condensing temperature−80 ◦C’.
2.11. Tracking of extracellular vesicles
The EBC samples were analyzed (undiluted) for pres-
ence of extracellular vesicles using NTA on a LM10-
HS system (Malvern Instruments Ltd, Malvern, UK)
equippedwith a 405 nm laser and a Luca-DL EMCCD
camera (Andor Technology, Belfast, UK) in accord-
ance with previous recommandations [20]. Silica
Microspheres (0.1 µm, Polysciences, Hirchberg, Ger-
many) were used to determine the software settings




In all seven pigs, the emboli settled in the central pul-
monary arteries. The hemodynamic phenotype of the
porcine PE model has been characterized in detail
previously [10]. The hemodynamic data of the seven
animals included in this study are summarized in
table 1. The pigs had significantly higher mean pul-
monary artery pressure and HR after PE, but pre-
served cardiac output andmean arterial pressure. The
end systolic volume of the right ventricle diameter
was larger after PE. Arterial blood gas analysis showed
higher PaCO2 after PE (table 1). Due to hypoxemia
during transport from the MRI center to the research
facility two of the pigs were given supplemental oxy-
gen (FiO2 of 0.75–1.0) during collection of Post PE
EBC samples, tidal volume and respiratory rate was
however unaltered (figure 1). The PaO2 was signific-
antly lower after PE if these two pigs were excluded
from the analysis (table 1 and supplementary table 1).
3.2. Volume of exhaled air, EBC, protein amount
and concentrations
The mean minute ventilation was 6.9 ± 0.2 l min−1
with no differences according to condensing
temperature (p-value = 0.79), the respiratory fre-
quency and tidal volume was unaltered throughout
the experiment in each pig (i.e. unaltered before and
after PE). The mean volume of EBC was significantly
higher when condensing temperature was −80 ◦C
instead of −21 ◦C (figure 2, table 2). The mean
protein concentration in all the EBC samples was
5.85 ± 0.93 µg ml−1, not significantly altered by the
condensing temperature (table 2, figure 2). The mean
protein amount was 6.52 ± 1.04 µg per EBC sample
with significantly higher amounts when collected at
−80 ◦C compared with EBCs collected at −21 ◦C
(9.91 µg and 3.33 µg, respectively, table 2, figure 2).
Collection times were longer, although not signific-
antly, for EBC samples collected at−80 ◦C (15.1 min
for EBC collected at −21 ◦C vs 18.1 min for those
collected at −80 ◦C, p-value 0.13) (table 2), and,
therefore, sampled from larger volumes of exhaled
air (104.1 l for the EBCs collected at −21 ◦C vs
123.75 l for the EBCs collected at −80 ◦C, p-value
0.05) (table 2).
The total protein amount and the protein concen-
tration in the EBC did not differ in the Pre PE EBC
5
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Figure 2. Volume of EBC, total protein yield, protein concentrations in the EBC plotted against initial collection temperature
(n= 9 at−21 ◦C and n= 5 at−80 ◦C). Boxes indicate median and interquartile range (25th–75th percentiles), whiskers indicate
lower and upper values within 1.5 times the interquartile range.
Table 2. Volumes of EBC, protein amounts and concentrations according to initial condensing temperature. Values are expressed as
mean± SEM.
Initial condensing temperature −21 ◦C −80 ◦C p-value
n EBC samples= 9 n EBC samples= 5
EBC vol. (ml) 0.71± 1.23 1.78± 0.25 <0.001a
Protein amount (µg)c 3.33± 0.76 9.91± 1.45 <0.001b
Protein concentration in the EBC (µg ml−1)c 5.33± 1.60 6.36± 1.01 0.59b
Collection time (min) 15.1± 0.2 18.1± 0.8 0.13a
Respiratory minute volume (l) 6.9± 0.3 6.8± 0.22 0.79a
Abbreviations: SEM, standard error of the mean; EBC, exhaled breath condensate; vol., volume; PE, pulmonary embolism.
a Wilcoxon-rank sum.
b t-test.
c Estimated by tryptophan fluorescence.
compared with the Post PE EBC, p-values 0.58 and
0.26, respectively (table 3, figure 3).
In summary, the total protein yield was higher
when the initial condensing temperature was−80 ◦C
compared with an initial condensing temperature of
−21 ◦C. No differences in total protein yield or con-
centrations in the EBC was observed after PE com-
pared with before PE.
3.3. Label-free quantification and bioinformatics
A total of 254 proteins were successfully identified in
the EBC samples (supplementary table 2). The aver-
age number of proteins per sample was 209 (range
166–234). A total of 131 proteins were identified and
quantified in all EBC samples (supplementary table
2). These 131 proteins were grouped according to
their cellular localization using the bioinformatics
tool GeneCodis3 [16–18]. A protein can be loc-
alized in more than one cellular compartment.
Cellular compartments of the identified proteins
were described as cytoplasm (73 proteins), cytosol
(47 proteins), nucleus (40 proteins), extracellular
region (31 proteins), plasma membrane (28 pro-
teins), mitochondrion (18 proteins), intracellular (13
proteins), soluble fraction (12 proteins), cytoskel-
eton (11 proteins), extracellular space (11 proteins),
melanosome (11 proteins) and protein complex (10
proteins), (supplementary figure 2). The levels of five
proteins were significantly different in EBC samples
collected after PE compared with EBC samples col-
lected before PE; for two of the proteins, the levels
were up to 29 fold higher after PE (P81245, P30086)
while for the remainder three proteins the levels
were lower after PE (P06753-4, P31949, P13797-3)
(p-values < 0.05).
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Table 3. Volumes of EBC, protein amounts and concentrations before vs after PE. Values are expressed as mean± SEM.
EBC samples Before PE (n= 7) After PE (n= 7) p-value
EBC vol. (ml) 1.46± 5.26 2.09± 7.71 0.09
Protein amount (µg) 10.36± 4.49 8.57± 2.80 0.58
Protein concentration in the EBC (µg ml−1) 7.37± 2.15 4.12± 0.81 0.26
Collection time (min) 15.5± 0.8 16.7± 0.9 0.16
Respiratory minute volume (l) 6.8± 0.35 Unaltered —
Abbreviations: SEM, standard error of the mean; EBC, exhaled breath condensate; vol., volume; PE, pulmonary embolism.
Figure 3. Volume of EBC, total protein yield, protein concentrations in the EBC plotted against collection period. Boxes indicate
median and interquartile range (25th–75th percentiles), whiskers indicate lower and upper values within 1.5 times the
interquartile range of seven samples.
3.4. Principal component analysis (PCA)
In order to reveal whether there was a difference in
protein composition between samples obtained at the
two different condensing temperatures we performed
a PCA. The first two components, explaining more
than 60% of the total variance of the data, are plot-
ted in figure 4. The data points were uniformly spread
with no separate grouping of neither EBC obtained
at −21 ◦C nor those obtained at −80 ◦C. Thus, the
PCA did not reveal any difference in the protein com-
position of EBC samples obtained at the two different
condensing temperatures (figure 4).
3.5. Extracellular vesicles
No extracellular vesicles could be detected using
Nano-sight analysis, neither before nor after PE.
4. Discussion
The porcine model corresponded to acute
intermediate-high-risk PE [3, 10]. EBCs were
collected before and after PE in all seven pigs. The
method yielded sufficient sample material for protein
quantification by proteomic analysis, and collection
at −80 ◦C was significantly better than −21 ◦C. We
demonstrated that our method was able to identify
and quantify 131 EBC proteins which were present in
all EBC samples. Considering the low protein content
of the EBC [21–23], a total of 131 successfully iden-
tified proteins in all samples is a fairly high number.
Thus, there was good consistency in the proteomic
analysis by LC-MS/MS. We required each protein
to be identified and quantified in all EBC samples.
This is a strict criteria considering the low abund-
ance of proteins in the EBC. Furthermore, some of
the proteins revealed a significant difference from
before to after PE indicating a potential as diagnostic
biomarkers.
As the EBC has a low cellular content [24], a
high number of extracellular proteins was likely to be
identified in the EBC. Nevertheless, the bioinformatic
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Figure 4. PCA of protein composition in EBC samples collected at−21 ◦C (•) (n= 9) and−80 ◦C () (n= 5). The protein
composition of the EBC samples do not differ according to initial condensing temperature.
analysis revealed that relatively large numbers of pro-
teins localized in the cytoplasm, cytosol, nucleus
and plasma membrane were identified in the EBC
(supplementary figure 2).
This is the very first study to investigate the pro-
tein content of EBC in PE. To the best of our know-
ledge only one other research group has collected EBC
from pigs, however not during mechanical ventila-
tion; the protein concentrations of EBC samples in
our study are comparable to their findings [25]. A
recently published study on the proteome of EBC in
humans collected the EBC by the RTube commercial
device identified 145 unique proteins in two pooled
samples of EBC by nano LC-MS/MS [26]. We identi-
fied 79 orthologs of these proteins in all of our EBC
samples. The initial condensing temperature did not
influence the protein concentration in EBC samples,
which confirms earlier observations [27, 28] but the
protein yield was considerably higher at −80 ◦C
because larger volumes of EBC were obtained and
probably more efficiently condensed as the condens-
ing temperature was low for a longer period.
The primary objective of our studywas to demon-
strate that proteins of the EBC prior to PE and after
PE could be identified and quantified using label-
free LC-MS/MS. Our study demonstrates that the use
of a porcine model of experimental PE combined
with LC-MS/MS has the potential to identify pro-
teins in EBC with a different composition following
PE. Plasma is the most commonly used material in
the search for biomarkers for PE. We demonstrated
that the EBC is a potential source for biomarkers and
a possible alternative to plasma. Although the res-
ults indicated some potential candidates, the study is
too preliminary to suggest putative diagnostic mark-
ers for PE. The findings must be confirmed in larger
studies.
4.1. Study limitations and strengths
We cannot rule out that the transitory hypoxemia and
accordingly higher FiO2 in two of the pigs make their
post PE EBC protein profile differ from the other five
pigs. Since specific proteomics is not within the scope
of this pilot study, we consider this a minor limita-
tion only. Transitory hypoxemia should not change
the effect of condensing temperature on protein con-
centration of the EBC or the protein concentration in
the EBC to such a degree that these animals ought to
be excluded.
As the study protocol encompassed MR scans,
Gadolinium contrast (0.1 ml, 279.3 mg ml−1,
Dotarem®, Guerbet, France) was added to the
blood right after distribution to the tubes [10].
Gadolinium does not bind to proteins in vitro
(www.drugs.com/pro/dotarem.html), thus neither
interactionswith proteinsmeasured in EBCnor inter-
actions with the coagulation should be a matter of
concern, but cannot be ruled out completely.
The coagulation in this model for formation of
thrombi is activated by contact activation, and it may
therefore not be completely equivalent or comparable
to an embolus formed in vivo. However, it has in
the recent years become clear that contact activa-
tion probably is important in the pathophysiolo-
gical formation of thrombi [29] and therefore the
approach used here is probably a reasonable method
to resemble the in vivo situation.
The experimental animals were their own con-
trols within few hours before exposure to autologous
PE, which is rather unique and a great advantage since
this paired study design minimizes inter-individual
variation of protein expression. Also, importantly, the
controlled volume of exhaled breath during mechan-
ical ventilation minimizes variations in EBC volumes
caused by individual breathing patterns [8, 30].
Mechanical ventilation hinders the normal physiolo-
gical response to hypercapnia (i.e. hyperventilation).
This is a limitation for the generalizability for the
PE model, as discussed previously [10]. However, we
find no reason to believe that it would influence the
observed effect of the condensing temperature on the
EBC or have a major effect on the protein content.
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4.2. Clinical implications
The EBC collection is gentle in its non-invasive
nature. This method would be applicable to mech-
anically ventilated patients with suspected PE. How-
ever the method would probably also be feasible in
the vast majority of conscious patients suffering a PE
of whom some may be severely dyspneic, as a previ-
ous study have shown that even patients with severe
heart failure can cooperate to breath analysis without
adverse events [31]. However, the potential of this
method may of course be demonstrated in studies
with humans having PE.
4.3. Conclusion
This study showed that EBC collected from pigs
before and after autologous intermediate-high-risk
PE yielded sufficient amounts of protein for identific-
ation and quantification with proteomic analysis by
nLC-MS/MS. Lower initial condensing temperature
increased the total protein yield by increasing the EBC
volume, but did not affect the protein concentration
in the EBC or the overall protein composition in the
EBC samples. Our methods demonstrated high con-
sistency in the protein analyses and allowed for quan-
tification of a great variety of proteins with different
cellular localizations. In conclusion our study indic-
ates that EBC could be an interesting new source of
PE biomarkers and an alternative to plasma.
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